Upcoming Webinars

cancel
Showing results for 
Search instead for 
Did you mean: 

Upcoming Webinars

Wednesday, March 27, 2024
With a new generation of cloud HPC and AI tools, computational chemistry and materials science is scaling and accelerating R&D efforts that could address some of our world’s toughest challenges. While there are few concrete examples of computational discoveries that have been validated experimentally, a shift is finally starting to take place.    In this special session, Microsoft will share some of its latest updates, including how a collaboration with Pacific Northwest National Laboratory is demonstrating methods to accelerate scientific discovery for energy storage solutions. Together, the teams have been able to discover and synthesize a material that shows potential for resource-efficient batteries in less than nine months. We will explore how advancements in HPC and AI are accelerating the next frontier of scientific breakthroughs, in turn compressing the next 250 years of chemistry into the next 25.    Key Learning Objectives: Learn how cloud-based high-performance computing and artificial intelligence can scale and accelerate discovery in materials science.  Explore one of Microsoft’s latest computational discoveries that was accelerated using Azure Quantum Elements.  Find out how Microsoft collaborated with Pacific Northwest National Laboratory to discover and synthesize a material to advance sustainable energy-storage solutions.  Discover how industry innovators adopted Azure Quantum Elements to transform their research and development.  Who Should Attend: Computational Materials Scientists  R&D Leaders  Computational Chemists  Digitization Managers C-suite  Brought to you by: Speakers: Dr. Nathan Baker Azure Quantum Elements Product Leader, Microsoft Melissa O'Meara Forensic Science Consultant, C&EN Media Group
%7B07626443-3325-42b6-943a-872ca92cc3a0%7D_16-PNNL
Labels (2)
  Vaccines based on mRNA technology demonstrated notable success during the COVID-19 pandemic. A crucial aspect of their efficacy lies in a formulation using lipid nanoparticles, enabling mRNA to enter the cell interior and initiate spike protein synthesis in the ribosomes. This formulation typically comprises four components, with particular emphasis on two: ionizable lipids and PEG lipids. To meet the demands of a large patient population during the pandemic, substantial quantities of lipids were required for vaccine production, necessitating a rapid scale-up of manufacturing processes.   This webinar will explore the specific requirements for industrializing processes in the production of ionizable lipids and PEG lipids, elucidating concepts to address typical challenges. Frequent restrictions include high molecular weight, the oily nature of pure substances, and the often absent chromophore. Both purification and analytics present unique challenges that must be carefully considered during synthesis.     Key Learning Objectives: Understand the essential requirements for scaling up processes and producing key lipids for Nano Particles. Identify specific challenges in lipid production and develop effective strategies to overcome them. Gain insights into the analytical aspects of lipid process research and development (R&D) and scale-up.   Who Should Attend: Researchers with focus on process scale-up Chemists and other scientists from Academia interested in recent developments in the pharmaceutical industry Lab technicians   Brought to you by:   Speakers: Joerg Jung Sr. Director Small Molecule Development Curia Global     Melissa O'Meara Forensic Science Consultant, C&EN Media Group  
%7B9c15be49-40e8-4437-b806-6eac2f24abf5%7D_Banner_for_C_EN_Webinar
Labels (2)